UNSPSC 51391708: Denopamine

This classification denotes a beta-adrenergic agonist with the molecular formula C18H23NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V5F60UPD8P, chemically known as (-)-(r)-alpha-(((3,4-dimethoxyphenethyl)amino)methyl)-p-hydroxybenzyl alcohol but generally known as denopamine, which bears US NIH Compound Identifier 71754. European Medicines Agency schedules Denopamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06977MIG.

UNSPSC 51391708 Denopamine, a Commodity code, describes pharmaceutical products that state and local governments procure for emergency medical response and public health initiatives. Recent solicitation activity shows demand focused on naloxone and drug deactivation systems rather than denopamine specifically, indicating that the code's nominal scope may not align tightly with current state and local purchasing patterns. Issuing bodies soliciting under or near this code include county health departments and public safety agencies managing community health and emergency preparedness programs.

Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The bid required electronic submission through the county's e-Procurement Portal, included shipping and delivery costs in vendor proposals, and carried a two-year initial term with a one-year renewal option. The solicitation imposed standard compliance requirements—drug-free workplace certification, E-Verify authorization, and insurance coverage including workers' compensation and commercial general liability—and noted potential FEMA funding with associated federal regulatory obligations. Geographic activity centers on Florida based on this recent record; the source supports no other state or jurisdiction opportunities under this code.